
This drug can extend lifespan? Scientists find a pill that may boost longevity
Now, new research suggests that a combination of existing drugs may offer a more practical alternative.
A study by the
University of East Anglia's School of Biological Sciences
found that two FDA-approved medications — Rapamycin and Metformin, already used for other purposes — could mimic the effects of dietary restriction and potentially increase lifespan. While results are largely based on animal studies, the findings are generating excitement among biologists and longevity researchers, with human trials currently underway to determine whether the same benefits might apply to people.
How the drug mimics calorie restriction to extend lifespan
One of the most consistent findings in aging research is that eating less, without malnutrition, can extend lifespan in many species. However, maintaining long-term dietary restriction is difficult for most people. The new study focused on Rapamycin and Metformin, drugs that replicate the cellular response to fasting. These medications act on nutrient-sensing pathways in the body, essentially 'tricking' cells into behaving as if they are in a low-calorie environment.
In mice, this has led to increased longevity and improved metabolic health.
Scientists examined over 160 studies involving vertebrates like fish, rodents, and monkeys to assess how these drugs affect lifespan. They discovered that while calorie restriction consistently produced longevity benefits across sexes and species, Rapamycin, when used individually, also showed a notable increase in lifespan — in some cases by as much as 30 percent.
However, results weren't always uniform.
In rare cases, the same drugs or diets led to shortened lifespan, highlighting the need for more targeted research.
Early signs from human trials
Although most of the existing evidence is from animal models, early human trials of Rapamycin have already begun. Researchers are testing low doses of the drug to reduce side effects while preserving its longevity-enhancing effects. Preliminary results are not yet published, but early data suggest potential improvements in immune response and cellular repair.
Scientists remain cautiously optimistic, emphasizing that it will take several years before conclusive evidence in humans is available.
Risks and limitations
Despite the excitement, experts urge caution. Rapamycin, in particular, is known to suppress the immune system at higher doses — a serious concern for long-term use. Metformin, commonly prescribed for type 2 diabetes, has shown fewer risks but also weaker effects on longevity. Additionally, what is effective in rodents doesn't always translate to human biology. Until large-scale, peer-reviewed clinical trials confirm safety and effectiveness, these pills remain a possibility rather than a prescription for longer life.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Time of India
9 hours ago
- Time of India
US lawmakers press FDA to target knockoff weight-loss drugs
Dozens of lawmakers are urging US health regulators to crack down on the booming market for knockoff weight-loss drugs amid mounting concerns over their potential safety risks. On Friday, a group of more than 80 bipartisan lawmakers asked the US Food and Drug Administration to stop counterfeit and copycat versions of GLP-1 drugs like Wegovy and Zepbound from flooding the market-a problem that emerged over the last year. Explore courses from Top Institutes in Please select course: Select a Course Category Cybersecurity MCA Data Science Degree Leadership PGDM Public Policy Operations Management others Others Product Management healthcare Digital Marketing MBA Technology Project Management CXO Finance Artificial Intelligence Healthcare Data Analytics Management Design Thinking Data Science Skills you'll gain: Duration: 10 Months MIT xPRO CERT-MIT xPRO PGC in Cybersecurity Starts on undefined Get Details "We are concerned about recent reports revealing a surge in illegal and counterfeit anti-obesity medications," they wrote in a letter to FDA commissioner Marty Makary. "Undoubtedly, illegal counterfeit medications pose an increased risk to patient safety with sometimes fatal consequences." by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Play War Thunder now for free War Thunder Play Now Undo The group-spearheaded by Representatives Richard Hudson of North Carolina and Herb Conaway of New Jersey-asked the agency to ramp up enforcement over illegally imported weight-loss drugs. They suggested issuing warning letters and better monitoring non-compliant online retailers and so-called compounding pharmacies that sell the medicines. The lawmakers also said the FDA should work in tandem with US Customs and Border Patrol agents to stop Chinese entities from shipping unsafe weight-loss drugs into the US. They requested an update on the FDA's efforts by July 30, given the "urgency" of the situation. Live Events A spokesperson for the FDA said the agency will work with the US Department of Health and Human Services to provide a "complete and thorough" response to the issues raised in the lawmakers' letter. "Any effort to undermine America's supply of safe medicines is an issue that FDA takes seriously," the spokesperson said. "And we are deeply committed to strengthening the oversight of imported products at US ports of entry." In recent years, the popularity of GLP-1 drugs has led to an explosion of copycats and counterfeits made by companies seeking to capitalise on the hype. State-licensed pharmacies were temporarily allowed to make copies of the drugs during a supply shortage but are no longer permitted to do so after Novo Nordisk and Eli Lilly boosted production. Still, some pharmacies have refused to wind down their operations while others have pivoted to selling the drugs in lower doses in order to avoid regulatory scrutiny. Counterfeit drugs are made by unregistered entities typically using illegally imported ingredients. As recently as April, there continue to be instances when counterfeit Ozempic pens covertly enter the drug supply chain undetected. Some patients are also purchasing ingredients directly from online sellers in an attempt to make the drugs themselves at home. In both cases, the medications don't go through the same rigorous approval process as brand-name drugs made by Novo and Lilly. Experts worry the lack of oversight is putting patients at risk. The FDA has said it's aware of hospitalisations potentially linked to the copycat drugs, but that adverse events are likely being underreported. "We support the bi-partisan call for the FDA to crack down on counterfeit and illegally sold weight-loss drugs," said a spokesperson for Hims & Hers Health, one of the telehealth firms that sells compounded GLP-1s. "We appreciate lawmakers' recognition that legitimate compounded medications dispensed by state-regulated pharmacies are not counterfeit. Patient safety must always come first." Novo and Lilly have discouraged consumers from using compounded and counterfeit products, including suing telehealth firms that sell the copycat versions and working with border agents to seize illegal shipments.


Time of India
9 hours ago
- Time of India
Late Bhanutai Gadkari Memorial Diagnostic Centre inaugurated: MRI at Rs1,200, CT Scan at Rs800, X-ray at Rs100
Nagpur: A state-of-the-art 6,000 sq ft facility in north Nagpur will be offering essential diagnostic and dialysis services at some of the lowest rates in the country — MRI for Rs1,200, CT Scan for Rs800, and digital X-ray for just Rs100, and major blood tests at Rs300, which otherwise cost thousands. Remarkably, it is India's first diagnostic centre equipped entirely with "Made-in-India" machines. The late Bhanutai Gadkari Memorial Diagnostic Centre, which was inaugurated on Sunday, has come as a major boost for healthcare infrastructure in north Nagpur. Located at Kamal Chowk, Lashkaribagh, the centre is dedicated to memory of Bhanutai Gadkari, mother of Union minister for road transport and highways, Nitin Gadkari, who presided over the programme when chief minister Devendra Fadnavis inaugurated the facility. "This diagnostic centre will be a milestone in the healthcare sector. Combining empathy with service, it sets an example of how indigenous technology can be used to bring down the cost of essential diagnostics for the common man," said Fadnavis while praising Gadkari's initiative. Gadkari, on an emotional note, said that the centre is not a commercial project, but a service mission inspired by his mother's legacy for compassion and empathy. Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Your IQ Is 140 If You Can Answer 10 of These Questions Correctly. IQ International Undo by Taboola by Taboola "From my first day in public life, her blessings guided me to serve the poor and suffering," said Gadkari and made an appeal to include bone marrow, sickle cell and thalassaemia treatments under the Mahatma Jyotiba Phule Jan Arogya Yojana. The fully air-conditioned centre, run by the late Bhanutai Gadkari Gramin Vikas Sanstha, features a modern waiting area, paperless operations, high-capacity servers, and trained technical staff. All MRI and CT scan machines have been manufactured in India, in collaboration with AMTZ (Andhra Pradesh MedTech Zone), significantly cutting costs compared to imported equipment. "This is the first time in India that a diagnostic centre has been established with 100% indigenous machines. We used to import MRI machines for Rs6 crore. Now, we are making them at Rs2 crore and exporting them too," said Dr Jitendra Sharma, managing director of AMTZ. # WHAT CENTRE OFFERS MRI – Rs1,200: High-end 1.5 Tesla imaging with 16-channel MUSIC technology ensuring quick scans with excellent image quality CT Scan — Rs800: BIS, AERB and CDSCO-approved fast scanning machines. Full chest scans done in just 6 seconds Digital X-ray — Rs100; high-resolution, modern digital imaging Dialysis — Rs750 standard, only Rs250 if NMC provides ₹500 subsidy—free dialysis for donor-backed patients Pathology Tests — Rs300; over 40 common tests included Pharmacy — Generic medicines available at 10% discount


Time of India
9 hours ago
- Time of India
Popular ice cream brands recalled across US after labeling error
More than a dozen popular ice cream products are being recalled nationwide after a labeling error that could put people with milk allergies at risk, the Food and Drug Administration ( FDA ) says. Tropicale Foods , based in Ontario, California, announced the voluntary recall Friday(July 25) for select Helados Mexico and La Michoacana ice cream products. The issue is the labels list 'cream' as an ingredient, but not 'milk,' a major allergen under federal law. Explore courses from Top Institutes in Please select course: Select a Course Category Operations Management PGDM Technology Finance Healthcare MBA Digital Marketing Project Management Cybersecurity Data Analytics Leadership Artificial Intelligence Management MCA others Product Management Data Science Design Thinking CXO Others Data Science Degree Public Policy healthcare Skills you'll gain: Quality Management & Lean Six Sigma Analytical Tools Supply Chain Management & Strategies Service Operations Management Duration: 10 Months IIM Lucknow IIML Executive Programme in Strategic Operations Management & Supply Chain Analytics Starts on Jan 27, 2024 Get Details 'People who have an allergy or severe sensitivity to milk run the risk of serious or life-threatening allergic reaction if they consume these products,' the company said in a statement posted to the FDA's website. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Play War Thunder now for free War Thunder Play Now Undo What's affected The recall covers several single-flavor bars, coconut, strawberry , bubble gum, cookies and cream, and mango, along with 6-pack, 12-pack, and 16-pack multipacks sold nationwide. The affected 'best by' dates range from May 2026 to July 2027. Live Events Milk is one of nine major allergens that must be clearly labeled under federal law. Undeclared allergens can trigger severe reactions, including anaphylaxis, which can be life-threatening. So far, one illness linked to the recalled products has been reported, according to the company. What you should do If you have any of the recalled products and are allergic or sensitive to milk, do not eat them, the FDA warns. Consumers should throw them away or return them to the store for a refund. For questions, contact Tropicale Foods at 909-563-3090, Monday through Friday, from 8 am to 5 pm PT.